NLS Pharmaceutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 (NCT05914194) | NLS Pharmaceutics | 2024-07-15 |
| An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy (NCT05055024) | NLS Pharmaceutics | 2021-10-26 |
| Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy (NCT04923594) | NLS Pharmaceutics | 2021-09-13 |
Track NLS Pharmaceutics automatically
Every clearance here is in the API, with alerts when new ones post.